Prisma Health is participating in a national clinical trial to test the effectiveness of blood plasma in treating severe coronavirus cases, hospital officials announced Wednesday, April 15.

The treatment is developed from the plasma of recovered COVID-19 patients and then administered to hospitalized patients who have the life-threatening virus, according